Scientists Develop New Gut Health Measure That Tracks Disease

The Future of Gut Health: Beyond Bacteria to Bacterial Relationships For decades, understanding the gut microbiome has centered on which bacteria live within us. Now, a groundbreaking study led by Rutgers University is shifting the focus to how those bacteria interact. This isn’t just a subtle change in perspective; it’s a potential revolution in diagnosing … Read more

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

Prostate Cancer Treatment Breakthrough: Combining Immunotherapy and Hormone Therapy Shows Promise A new study led by Mayo Clinic, published in Cell Reports Medicine, reveals a potentially game-changing approach to treating early-stage prostate cancer. Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery can overcome a significant hurdle in treatment – the … Read more

Adeline Blondieau : Her poignant confession about her husband’s cancer battle

Adeline Blondieau’s Cancer Revelation: A Shift Towards Openness in Health Discussions Adeline Blondieau, known for her work as an actress and now a sophrologist, recently shared her family’s experience with her husband’s cancer diagnosis. In an interview with Rewell Mag, published on YouTube on February 23rd, she explained her decision to openly discuss the illness, … Read more

Targeting glutamine metabolism offers new hope for synovial sarcoma treatment

Cutting Off the Fuel: How Targeting Glutamine Could Revolutionize Cancer Treatment For years, cancer treatment has focused on directly attacking tumor cells – with surgery, radiation, and chemotherapy. But what if we could weaken cancer from within, starving it of the very nutrients it needs to survive? Emerging research suggests this isn’t just a possibility, … Read more

FDA Rejection of Cancer Therapy Sparks Questions Over Agency Leadership

FDA Rejection of Rare Disease Therapy Sparks Debate Over Agency Direction A promising cell therapy developed by Atara Biotherapeutics and Pierre Fabre Pharmaceuticals for a rare blood cancer faced a sudden reversal in its path to FDA approval. Internal reviewers had previously recommended clearance, yet the agency rejected the drug last month, citing insufficient clinical … Read more

Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the U.S. – ABC 6 News

Mayo Clinic Pioneers a New Era in Cancer Treatment with Magnetic Hyperthermia Rochester, Minnesota – The Mayo Clinic has taken a significant leap forward in cancer research, becoming the first U.S. Institution to install and utilize a magnetic nanoparticle hyperthermia system. This groundbreaking technology, developed in collaboration with New Phase Ltd., offers a novel approach … Read more

Valencia Councillor Glòria Tello Returns to Work After Breast Cancer Battle

Valencia Councillor Returns to City Hall After Battling Breast Cancer Valencia City Councillor Glòria Tello returned to the plenary session of the city council on Tuesday, February 24, 2026, after a ten-month absence due to breast cancer treatment. Her return was met with emotional support and applause from fellow councillors across the political spectrum. A … Read more

Colonoscopy and FIT at age 60 catch colorectal cancer earlier

Colorectal Cancer Screening at 60: A Shift Towards Earlier Detection Inviting adults for colorectal cancer (CRC) screening at age 60 appears to identify more cancers at earlier, more treatable stages. Although, a large Swedish study, the SCREESCO randomized controlled trial, reveals this doesn’t immediately translate to lower short-term death rates. This highlights the complex trade-offs … Read more

Major breakthrough in battle against dementia: Experts ‘finally unlock’ mystery of why CANCER survivors are less likely to develop cognitive disease

The Unexpected Link: How Cancer Research Could Unlock Alzheimer’s Treatments For decades, scientists have observed a puzzling phenomenon: individuals who survive cancer appear to have a significantly lower risk of developing dementia. Now, groundbreaking research is beginning to unravel this mystery, pointing to a surprising connection between tumor cells and the fight against Alzheimer’s disease. … Read more

Bayer Sues J&J Over Prostate Cancer Drug Advertising Claims

Bayer Challenges J&J’s Erleada Marketing Claims in Court German pharmaceutical company Bayer has launched a lawsuit against Johnson & Johnson (J&J) and its subsidiary Janssen Biotech, alleging false advertising related to their prostate cancer drugs, Erleada and Nubeqa. The legal action, filed in the United States District Court for the Southern District of New York, … Read more